It has been shown that miR-384 targets PIWIL4 3′-UTR and suppresses glioma cell malignancy via regulating the expression of cyclin D1, VEGFA, SNAI2, MMP-9, Bcl-2, Bcl-xL and Caspase 3 genes [53]. The gene discussed is BCL2; the disease is central nervous system cancer.